Aj. Shaer et A. Rastegar, Lactic acidosis in the setting of antiretroviral therapy for the acquired immunodeficiency syndrome - A case report and review of the literature, AM J NEPHR, 20(4), 2000, pp. 332-338
Type B lactic acidosis, a rare but often fatal disorder, has been reported
in 21 AIDS patients on antiretroviral therapy (ART). We present an AIDS pat
ient with severe and prolonged lactic acidosis on stavudine and lamivudine,
The lactic acidosis occurred in the absence of mitochondrial myopathy, hep
atomegaly, or liver failure. This is the second report of lactic acidosis i
n a patient on stavudine and lamivudine. This patient recovered after aggre
ssive supportive therapy including intravenous alkali and fluid administrat
ion as well as continuous venovenous hemodiafiltration, A single dose of di
chloroacetate (DCA) was associated with a decrease in the serum lactate lev
el by 20%, which persisted for more than 24 h. Seventeen months after recov
ery, the patient was rechallenged with ART without recurrence of lactic aci
dosis. We review and summarize all reported cases of patients with ART-asso
ciated lactic acidosis reported in the English literature. Copyright (R) 20
00 S. Karger AG. Basel.